SEC Form 3 · accession 0002155916-26-000003
Mirum Pharmaceuticals, Inc. · MIRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Paul Myers
Officer — Chief Medical Officer
Period of report
Sep 21, 2026
Accepted (ET)
Sep 22, 2026 · 9:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001759425
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 55 | D |
Table II — derivative securities
No Table II lines on this filing.